Ultragenyx Pharmaceutical Inc (NASDAQ:RARE)

69.65
Delayed Data
As of Apr 24
 +0.75 / +1.09%
Today’s Change
32.02
Today|||52-Week Range
70.47
+58.73%
Year-to-Date

Today’s Trading

Previous close68.90
Today’s open68.90
Day’s range68.30 - 70.47
Volume191,130
Average volume (3 months)321,927
Market cap$2.5B
Dividend yield--
Data as of 3:59pm ET, 04/24/2015

Growth & Valuation

Earnings growth (last year)+84.87%
Earnings growth (this year)-3.06%
Earnings growth (next 5 years)+75.40%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book12.03

Competitors

 Today’s
change
Today’s
% change
CBPOChina Biologic Produ...-0.35-0.35%
LCILannett Company Inc0.000.00%
TSROTESARO Inc-0.65-1.01%
MYGNMyriad Genetics Inc-0.77-2.24%
Data as of 4:01pm ET, 04/24/2015

Financials

Next reporting dateMay 11, 2015
EPS forecast (this quarter)-$0.54
Annual revenue (last year)$0.00
Annual profit (last year)-$59.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Emil D. Kakkis
CFO, SVP-Finance &
Investor Relations
Shalini Sharp
Corporate headquarters
Novato, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers